{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:05:04Z","timestamp":1781715904576,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10096-024-04885-w","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T06:02:40Z","timestamp":1719986560000},"page":"1741-1751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-4400","authenticated-orcid":false,"given":"Fabi\u00e1n","family":"Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Laborde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Jord\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Tula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Ma\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Suchowiercha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Berruezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz Gonz\u00e1lez","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Eusebio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barc\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s Roccia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Pennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1ngeles","family":"Vis\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Reynaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Paster\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Angel","family":"Carena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for The Argentine Group for the Study of Bacteremia in Cancer, Stem Cell Transplant (ROCAS) Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Melia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Luck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Bronzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Benso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Vilches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Poletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"issue":"10","key":"4885_CR1","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258\u20132266. https:\/\/doi.org\/10.1002\/cncr.21847","journal-title":"Cancer"},{"issue":"5","key":"4885_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s15010-013-0468-1","volume":"41","author":"MM Bos","year":"2013","unstructured":"Bos MM, Smeets LS, Dumay I, de Jonge E (2013) Bloodstream infections in patients with or without cancer in a large community hospital. Infection 41(5):949\u2013958. https:\/\/doi.org\/10.1007\/s15010-013-0468-1","journal-title":"Infection"},{"issue":"8","key":"4885_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/bmt.2017.14","volume":"52","author":"CE Dandoy","year":"2017","unstructured":"Dandoy CE, Ardura MI, Papanicolaou GA, Auletta JJ (2017) Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis. Bone Marrow Transplant 52(8):1091\u20131106. https:\/\/doi.org\/10.1038\/bmt.2017.14","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"4885_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"EM Trecarichi","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, Nosari A, Caira M, Spadea A, Busca A, Vianelli N, Tumbarello M, HeMABISRegistry\u2014SEIFEM Group, Italy (2015) Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect. 21(4):337\u201343. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.022","journal-title":"Clin Microbiol Infect."},{"issue":"11","key":"4885_CR5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","volume":"65","author":"D Averbuch","year":"2017","unstructured":"Averbuch D, Tridello G, Hoek J et al (2017) Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the european bone marrow transplantation group. Clin Infect Dis 65(11):1819\u20131828. https:\/\/doi.org\/10.1093\/cid\/cix646","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4885_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/microorganisms11020359","volume":"11","author":"SA Cruz-Vargas","year":"2023","unstructured":"Cruz-Vargas SA, Garc\u00eda-Mu\u00f1oz L, Cuervo-Maldonado SI et al (2023) Molecular and clinical data of antimicrobial resistance in microorganisms producing bacteremia in a multicentric cohort of patients with cancer in a Latin American country. Microorganisms 11(2):359. https:\/\/doi.org\/10.3390\/microorganisms11020359","journal-title":"Microorganisms"},{"issue":"Suppl 1","key":"4885_CR7","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/ofid\/ofy347","volume":"6","author":"M Castanheira","year":"2019","unstructured":"Castanheira M, Deshpande LM, Mendes RE, Canton R, Sader HS, Jones RN (2019) Variations in the occurrence of resistance phenotypes and carbapenemase genes among Enterobacteriaceae isolates in 20 years of the SENTRY antimicrobial surveillance program. Open Forum Infect Dis 6(Suppl 1):S23\u2013S33. https:\/\/doi.org\/10.1093\/ofid\/ofy347","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"4885_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid2811.220415","volume":"28","author":"GR Thomas","year":"2022","unstructured":"Thomas GR, Corso A, Paster\u00e1n F et al (2022) Increased detection of carbapenemase-producing enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic. Emerg Infect Dis 28(11):1\u20138. https:\/\/doi.org\/10.3201\/eid2811.220415","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"4885_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/antibiotics12020226","volume":"12","author":"F Herrera","year":"2023","unstructured":"Herrera F, Torres D, Laborde A et al (2023) Development of a clinical score to stratify the risk for carbapenem-resistant Enterobacterales bacteremia in patients with cancer and hematopoietic stem cell transplantation. Antibiotics (Basel) 12(2):226. https:\/\/doi.org\/10.3390\/antibiotics12020226","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"4885_CR10","doi-asserted-by":"publisher","first-page":"e 56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 52(4):e 56-93. https:\/\/doi.org\/10.1093\/cid\/cir073","journal-title":"Clin Infect Dis."},{"issue":"11","key":"4885_CR11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00277-017-3098-3","volume":"96","author":"WJ Heinz","year":"2017","unstructured":"Heinz WJ, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely OA, Einsele H, Karthaus M, Link H, Mahlberg R, Neumann S, Ostermann H, Penack O, Ruhnke M, Sandherr M, Schiel X, Vehreschild JJ, Weissinger F, Maschmeyer G (2017) Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 96(11):1775\u20131792. https:\/\/doi.org\/10.1007\/s00277-017-3098-3","journal-title":"Ann Hematol"},{"key":"4885_CR12","doi-asserted-by":"publisher","unstructured":"Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH\/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98(12):1826\u201335. https:\/\/doi.org\/10.3324\/haematol.2013.091025. Erratum in: Haematologica. 2014;99(2):400.","DOI":"10.3324\/haematol.2013.091025"},{"key":"4885_CR13","doi-asserted-by":"publisher","unstructured":"Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH\/ESCMID and ELN. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013;98(12):1836\u201347. https:\/\/doi.org\/10.3324\/haematol.2013.091330.","DOI":"10.3324\/haematol.2013.091330"},{"issue":"4","key":"4885_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.eimc.2019.01.013","volume":"38","author":"C Gudiol","year":"2020","unstructured":"Gudiol C, Aguilar-Guisado M, Azanza JR et al (2020) Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies. Enferm Infecc Microbiol Clin (Engl Ed) 38(4):174\u2013181. https:\/\/doi.org\/10.1016\/j.eimc.2019.01.013","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"4885_CR15","doi-asserted-by":"publisher","unstructured":"Yahav D, Franceschini E, Koppel F, et al. Bacteremia Duration Study Group. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091\u20131098. https:\/\/doi.org\/10.1093\/cid\/ciy1054.","DOI":"10.1093\/cid\/ciy1054"},{"issue":"21","key":"4885_CR16","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1001\/jama.2020.6348","volume":"323","author":"E von Dach","year":"2020","unstructured":"von Dach E, Albrich WC, Brunel AS et al (2020) Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA 323(21):2160\u20132169. https:\/\/doi.org\/10.1001\/jama.2020.6348","journal-title":"JAMA"},{"key":"4885_CR17","doi-asserted-by":"publisher","unstructured":"Molina J, Montero-Mateos E, Praena-Segovia J, et al. SHORTEN trial team. Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial. Clin Microbiol Infect. 2022;28(4):550\u2013557. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.001.","DOI":"10.1016\/j.cmi.2021.09.001"},{"key":"4885_CR18","doi-asserted-by":"publisher","unstructured":"Turjeman A, von Dach E, Molina J, et al. Duration of antibiotic treatment for Gram-negative bacteremia \u2013 Systematic review and individual participant data (IPD) meta-analysis. eClinicalMedicine. 2022;55:101750. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101750.","DOI":"10.1016\/j.eclinm.2022.101750"},{"key":"4885_CR19","doi-asserted-by":"publisher","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002. Erratum in: Am J Infect Control. 2008;36(9):655.","DOI":"10.1016\/j.ajic.2008.03.002"},{"issue":"5","key":"4885_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/cid\/cis998","volume":"56","author":"L Nesher","year":"2013","unstructured":"Nesher L, Rolston KV (2013) Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis 56(5):711\u2013717. https:\/\/doi.org\/10.1093\/cid\/cis998","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4885_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791\u2013797. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007","journal-title":"Ann Intern Med"},{"issue":"12","key":"4885_CR22","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1128\/AAC.36.12.2639","volume":"36","author":"JA Korvick","year":"1992","unstructured":"Korvick JA, Bryan CS, Farber B, Beam TR Jr, Schenfeld L, Muder RR, Weinbaum D, Lumish R, Gerding DN, Wagener MM et al (1992) Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 36(12):2639\u20132644. https:\/\/doi.org\/10.1128\/AAC.36.12.2639","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"4885_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"4885_CR24","doi-asserted-by":"publisher","unstructured":"Harris PNA, Tambyah PA, Lye DC, et al. MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984\u2013994. https:\/\/doi.org\/10.1001\/jama.2018.12163. Erratum in: JAMA. 2019;321(23):2370.","DOI":"10.1001\/jama.2018.12163"},{"issue":"3","key":"4885_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"4885_CR26","doi-asserted-by":"publisher","unstructured":"Perez F, Adachi J, Bonomo RA. Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clin Infect Dis. 2014;59 Suppl 5(Suppl 5):S335\u20139. https:\/\/doi.org\/10.1093\/cid\/ciu612.","DOI":"10.1093\/cid\/ciu612"},{"key":"4885_CR27","unstructured":"Protocolos de PCR-Multiplex para Gram negativos. Available at: http:\/\/antimicrobianos.com.ar\/2023\/06\/protocolo-de-pcr-para-la-deteccion-del-gen-ctx-m\/. Accessed 20 Feb 2024."},{"issue":"16","key":"4885_CR28","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT (2015) Clostridium difficile infection. N Engl J Med 372(16):1539\u20131548. https:\/\/doi.org\/10.1056\/NEJMra1403772","journal-title":"N Engl J Med"},{"issue":"7","key":"4885_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Loo V, Shaklee Sammons J, Sandora TJ, Wilcox MH (2018) Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66(7):987\u2013994. https:\/\/doi.org\/10.1093\/cid\/ciy149","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4885_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2021.10.017","volume":"84","author":"A Metais","year":"2022","unstructured":"Metais A, Torregrosa Diaz JM, GallegoHernanz MP, Pichon M, Desmier D, Roblot F, Rammaert B (2022) Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study. J Infect 84(1):1\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2021.10.017","journal-title":"J Infect"},{"key":"4885_CR31","doi-asserted-by":"publisher","unstructured":"Ranganath N, Yetmar ZA, McCandless AR, Rivera CG, Lahr BD, Tande AJ, Shah AS. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation. Transpl Infect Dis. 2023:e14085. https:\/\/doi.org\/10.1111\/tid.14085.","DOI":"10.1111\/tid.14085"},{"issue":"2","key":"4885_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/microorganisms11020511","volume":"11","author":"F Herrera","year":"2023","unstructured":"Herrera F, Torres D, Carena A et al (2023) Short course of antibiotic therapy for gram-negative bacilli bacteremia in patients with cancer and hematopoietic stem cell transplantation: less is possible. Microorganisms 11(2):511. https:\/\/doi.org\/10.3390\/microorganisms11020511","journal-title":"Microorganisms"},{"key":"4885_CR33","doi-asserted-by":"publisher","unstructured":"Verlinden A, Jansens H, Goossens H, Anguille S, Berneman ZN, Schroyens WA, Gadisseur AP. Safety and efficacy of antibiotic de-escalation and discontinuation in high-risk hematological patients with febrile neutropenia: a single-center experience. Open Forum Infect Dis. 2021;9(3):ofab624. https:\/\/doi.org\/10.1093\/ofid\/ofab624.","DOI":"10.1093\/ofid\/ofab624"},{"issue":"8","key":"4885_CR34","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/cid\/ciy258.Erratum.In:ClinInfectDis.2018;67(7):1151","volume":"67","author":"R Ram","year":"2018","unstructured":"Ram R, Halavy Y, Amit O, Paran Y, Katchman E, Yachini B, Kor S, Avivi I, Ben-Ami R (2018) Extended vs bolus infusion of broad-spectrum \u03b2-lactams for febrile neutropenia: an unblinded, randomized trial. Clin Infect Dis 67(8):1153\u20131160. https:\/\/doi.org\/10.1093\/cid\/ciy258.Erratum.In:ClinInfectDis.2018;67(7):1151","journal-title":"Clin Infect Dis"},{"issue":"23","key":"4885_CR35","doi-asserted-by":"publisher","first-page":"00368","DOI":"10.1016\/j.jinf.2023.06.023","volume":"S0163\u20134453","author":"J Laporte-Amargos","year":"2023","unstructured":"Laporte-Amargos J, Ulldemolins M, Puig-Asensio M, Teb\u00e9 C, Castro S, Carratal\u00e0 J, Gudiol C (2023) Prolonged vs short-term infusion of \u03b2-lactam antibiotics for the treatment of febrile neutropenia: a systematic review and meta-analysis. J Infect S0163\u20134453(23):00368\u201300377. https:\/\/doi.org\/10.1016\/j.jinf.2023.06.023","journal-title":"J Infect"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04885-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04885-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04885-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T23:04:30Z","timestamp":1724799870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04885-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4885"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04885-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the CEMIC Ethics Committee on 30 April 2014 (Approval number 880) and the ethics committees from the different participating institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Patient participation in this study was voluntary, and a written informed consent was required until December 2016. Since then, patient consent was waived by the Ethics Committees due to this study continued as a registry of statistic, epidemiological, and scientific data, according to the point 2, article 7 of de law 25326, Protection of Personal Data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"F.H. has participated in advisory boards and\/or received speaker honoraria and grants from Gilead, Knight Therapeutics, Merck, Sharp & Dohme (MSD), TEVA and Pfizer. D.T. has participated in advisory boards and\/or received speaker honoraria from Gilead, Knight Therapeutics, MSD and GlaxoSmithKline. R.J. has participated in advisory boards and\/or received speaker honoraria from Gilead and Pfizer. L.T. has received speaker honoraria from MSD. C.G. has participated in advisory boards and\/or received speaker honoraria from Gilead, MSD, Pfizer and Mundipharma. S.L. has received speaker honoraria from MSD and Pfizer. F. P. has received speaker honoraria from MSD and Pfizer. AAC is an employee of ROCHE Diagnostics with the role of Regional Medical Lead for Latin America. All other authors report no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}]}}